Optical Coherence Tomography for Drug Eluting Stent Safety

PHASE4UnknownINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2008

Conditions
Coronary Artery Disease
Interventions
DEVICE

sirolimus drug eluting coronary stent Cypher™ (Cordis Corp, Johnson & Johnson Co)

comparison of multiple drug eluting stents

DEVICE

paclitaxel polymer drug eluting stent Taxus Libertè™ (Boston Scientific, Natick MS)

comparison of multiple drug eluting coronary stents

DEVICE

zotarolimus drug eluting coronary stent Endeavor™ (Medtronic, Santa Rosa, CA)

comparison of multiple drug eluting coronary stents

DEVICE

Libertè bare metal coronary stent Libertè™ BMS(Boston Scientific, Natick, MS)

comparison of DES in overlap vs BMS in overlap

Trial Locations (1)

24100

RECRUITING

Cardiovascular Department Ospedali Riuniti di Bergamo, Bergamo

All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

collaborator

Medtronic Vascular

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

lead

A.O. Ospedale Papa Giovanni XXIII

OTHER